K

Kernal Biologics

Develops onco-selective mRNA therapeutics

Associate Director/Director of Preclinical Development

Translational Research & Bench BiologyConfirmed live in the last 24 hours
Full-timeBoston, MA, USANo salary listedIn-person

About the Job

Requirements

  • A PhD or M.D./Ph.D. in toxicology, pharmacology, immunology, immuno-oncology, genetics, or a related field, with 7 or more years of biotech or pharmaceutical experience and 3 or more years in managerial roles; candidates with 5 or more years of experience may be considered for the Associate Director role.
  • Comprehensive knowledge of preclinical development in autoimmune diseases, with familiarity with immuno-oncology such as CAR-T preferred.
  • Expertise in state-of-the-art methods for exploring cancer cell–immune cell interactions and assay development for mechanistic characterization of development candidates.
  • A proven track record of scientific accomplishments demonstrated by publications, patent applications, and key contributions to Go/No-Go decisions.
  • Hands-on experience with multi-parameter flow cytometry, quantitative polymerase chain reaction, and Western blotting.
  • Familiarity with single-cell sorting and deep immune profiling, including multiplex approaches.
  • Experience collaborating with the FDA and other regulatory agencies, such as TGA, for preclinical and clinical development of autoimmune disease programs.
  • Extensive experience authoring key regulatory filings, such as IND/HREC submissions, and leading meetings with regulatory agencies.
  • Ability to maintain professional, productive relationships with internal and external stakeholders.
  • Proven success in managing scientists and associates effectively.
  • Prior experience with mRNA lipid nanoparticles and in vivo CAR-T therapies is preferred.

Responsibilities

  • Guide the company’s preclinical immunology efforts for mRNA 2.0 therapeutics.
  • Independently design, execute, oversee, and analyze preclinical pharmacology, toxicology, and DMPK studies for in vivo CAR-T programs.
  • Work collaboratively with internal and external cross-functional teams, collaborators, funding agencies, and scientific advisory board members to align, plan, and execute the overall research and development plans.
  • Stay up to date on scientific literature and the patent landscape, and prepare technical reports and white papers.
  • Lead regulatory filings with agencies, including the FDA, EMA, and TGA.
  • Manage contract research organizations and collaborate with academic and industry partners for external preclinical studies.
  • Plan and oversee timelines, budgets, and risk mitigation for preclinical programs.
  • Prepare and present preclinical program updates internally and externally.
  • Develop target product profiles and periodically revise them in response to internal data generation and ongoing landscape analysis.

Desired Qualifications

  • Prior experience with mRNA lipid nanoparticles and in vivo CAR-T therapies.

About the Company

Kernal Biologics

Develops onco-selective mRNA therapeutics

Kernal Biologics develops mRNA therapies that target cancer cells and infectious diseases like COVID-19. It uses a proprietary platform that combines synthetic biology and deep learning to design mRNA molecules that avoid triggering RNA-sensing pathways and to enable therapeutic protein expression in specific cell types. The product works by delivering engineered mRNA into target cells, where it instructs them to produce a therapeutic protein with restricted expression to reduce side effects. The company differentiates itself through onco-selectivity, its data-driven design process, and partnerships with healthcare providers, research institutions, and pharmaceutical companies. Revenue comes from collaborations, grants, and sales of its mRNA platforms and therapies. The goal is to provide effective, tolerable, and affordable mRNA medicines by advancing targeted, cell-specific therapies for cancer and infectious diseases.

Company size
11-50
Company stage
Series A
Total funding
$26.8M
Headquarters
Cambridge, MA
Founded
2016

Recently Posted Jobs

Explore more opportunities at Kernal Biologics

See more jobs